Electrotransfer of therapeutic molecules into tissues

Current Opinion in Molecular Therapeutics

Volumn 9, Issue 6, 2007, Pages 554-562

  Cemazar, M ^a   Sersa, G ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Clinical trial; Electroporation; Electrotransfer; Gene therapy

Indexed keywords

ALPHA INTERMEDIN; B7 ANTIGEN; BLOOD CLOTTING FACTOR 8; CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; FLT3 LIGAND; GAG PROTEIN; GANCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; HEPATITIS B SURFACE ANTIGEN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 24; PLASMID DNA; POL PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN VP1; PROTEIN VP3; SALMONELLOSIS VACCINE; SCATTER FACTOR; SMALL INTERFERING RNA; SOMATOMEDIN C; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ARTERY DISEASE; ARTHRITIS; ATHEROSCLEROSIS; CANCER; DIABETES MELLITUS; DNA TRANSFER; DUCHENNE MUSCULAR DYSTROPHY; ELECTROCHEMOTHERAPY; ELECTROPORATION; GENE SILENCING; GENE THERAPY; GRAFT REJECTION; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLAMMATION; LIVER FIBROSIS; LUNG INJURY; MULTIPLE SCLEROSIS; MUSCLE ATROPHY; MYOCARDITIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; ORGAN TRANSPLANTATION; PANCREAS CANCER; REVIEW; RNA INTERFERENCE; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SUICIDE GENE THERAPY; TUBERCULOSIS; UVEITIS; VACCINATION; VIRAL GENE DELIVERY SYSTEM; WOUND HEALING;

ANIMALS; ANTINEOPLASTIC AGENTS; ARTHRITIS; CANCER VACCINES; CLINICAL TRIALS AS TOPIC; ELECTROCHEMOTHERAPY; EUROPE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS; ORGAN TRANSPLANTATION; PLASMIDS; VACCINATION; VACCINES, DNA; VIRUSES;

EID: 36549053616     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH: Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J (1982) 1(7):841-845.
2. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D, Pavlovic I et al: Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl (2006) 4:3-13.
3. Inovio Biomedical Corp: Inovio Biomedical stops enrollment of phase III clinical trials for head and neck cancer. Press Release (2007): June 05. http://ir.inovio.com/phoenix.zhtml?c=105128&p=irolnews/ Articles&ID=1011346&highlight=
4. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M: Electrochemotherapy in treatment of tumours. Eur J Surg Oncol (2007): doi:10.1016/j.ejso.2007.05.016/.
5. Aihara H, Miyazaki J: Gene transfer into muscle by electroporation in vivo. Nat Biotechnol (1998) 16(9):867-870.
6. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B, Scherman D: High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA (1999) 96(8):4262-4267.
7. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J: In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol (1998) 16(2):168-171.
8. Heller R, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J, Nicolau C: In vivo gene electroinjection and expression in rat liver. FEBS Lett (1996) 389(3):225-228.
9. Nishi T, Yoshizato K, Yamashiro S, Takeshima H, Sato K, Hamada K, Kitamura I, Yoshimura T, Saya H, Kuratsu J, Ushio Y: High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res (1996) 56(5):1050-1055.
10. Titomirov AV, Sukharev S, Kistanova E: In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta (1991) 1088(1):131-134.
11. Cemazar M, Golzio M, Sersa G, Rols MP, Teissié J: Electrically-assisted nucleic acids delivery to tissues in vivo: Where do we stand? Curr Pharm Des (2006) 12(29):3817-3825. • Comprehensive review outlining the limitations of electrogene therapy in different tissues and how these limitations may be overcome.
12. Satkauskas S, Andre F, Bureau MF, Scherman D, Miklavcic D, Mir LM: Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther (2005) 16(10):1194-1201.
13. Pavselj N, Preat V: DNA electrotransfer into the skin using a combination of one high-voltage and one low-voltage pulse. J Control Release (2005) 106(3):407-415.
14. Jaichandran S, Yap ST, Khoo AB, Ho LP, Tien SL, Kon OL: In vivo liver electroporation: Optimization and demonstration of therapeutic efficacy. Hum Gene Ther (2006) 17(3):362-375.
15. Mesojednik S, Pavlin D, Sersa G, Coer A, Kranjc S, Grosel A, Tevz G, Cemazar M. The effect of histological properties of tumors on transfection efficiency of electrically assisted gene delivery to solid tumors in mice. Gene Ther (2006) 14(17):1261-1269.
16. Prud'homme GJ, Glinka Y, Khan AS, Draghia-Akli R. Electroporation- enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther (2006) 6(2):243-273.
17. Grønevik E, Mathiesen I, Lømo T: Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses. J Gene Med (2005) 7(9):1246-1254.
18. Peng B, Zhao Y, Xu L, Xu Y: Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity. Vaccine (2007) 25(11):2064-2073.
19. Kim JY, Jeon ES, Lim BK, Kim SM, Chung SK, Kim JM, Park SI, Jo I, Nam JH: Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: Protective effects of capsid proteins against viral challenge. Vaccine (2005) 23(14):1672-1679.
20. Kim SA, Liang CM, Cheng IC, Cheng YC, Chiao MT, Tseng CJ, Lee F, Jong MH, Tao MH, Yang NS, Liang SM: DNA vaccination against foot-and-mouth disease via electroporation: Study of molecular approaches for enhancing VP1 antigenicity. J Gene Med (2006) 8(9):1182-1191.
21. Yang NS, Wang JH, Lin KF, Wang CY, Kim SA, Yang YL, Jong MH, Kuo TY, Lai SS, Cheng RH, Chan MT, Liang SM: Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. J Gene Med (2005) 7(6):708-717.
22. Medi BM, Hoselton S, Marepalli RB, Singh J: Skin targeted DNA vaccine delivery using electroporation in rabbits. I: Efficacy. Int J Pharm (2005) 294(1-2):53-63.
23. Medi BM, Singh J: Skin targeted DNA vaccine delivery using electroporation in rabbits II. Safety. Int J Pharm (2006) 308(1-2):61-68.
24. Babiuk S, Tsang C, van Drunen Littel-van den Hurk S, Babiuk LA, Griebel PJ: A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. Bioelectrochemistry (2007) 70(2):269-274.
25. Shiau YT, Huang YH, Wu JC, Tao MH, Syu W, Chang FY, Lee SD: Analysis of humoral immunity of hepatitis D virus DNA vaccine generated in mice by using different dosage, gene gun immunization, and in vivo electroporation. J Chin Med Assoc (2006) 69(1):7-13.
26. Capone S, Zampaglione I, Vitelli A, Pezzanera M, Kierstead L, Burns J, Ruggeri L, Arcuri M, Cappelletti M, Meola A, Ercole BB et al: Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates. J Immunol (2006) 177(10):7462-7471.
27. Folgori A, Capone S, Ruggeri L, Meola A, Sporeno E, Ercole BB, Pezzanera M, Tafi R, Arcuri M, Fattori E, Lahm A et al: A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med (2006) 12(2):190-197. • This study demonstrated effective vaccine electrotransfer for the protection of chimpanzees from acute hepatitis by challenge with heterologous virus.
28. Otten GR, Schaefer M, Doe B, Liu H, Megede JZ, Donnelly J, Rabussay D, Barnett S, Ulmer JB: Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation. Vaccine (2006) 24(21):4503-4509.
29. Luckay A, Sidhu MK, Kjeken R, Megati S, Chong SY, Roopchand V, Garcia-Hand D, Abdullah R, Braun R, Montefiori DC, Rosati M et al: Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol (2007) 81(10):5257-5269. • This study demonstrated effective vaccination for the prevention of HIV-1 infection by electrotransfer in non-human primates.
30. Li Z, Zhang H, Fan X, Zhang Y, Huang J, Liu Q, Tjelle TE, Mathiesen I, Kjeken R, Xiong S: DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates. Vaccine (2006) 24(21):4565-4568.
31. Andersen P: Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun (1994) 62(6):2536-2544.
32. Zhang X, Divangahi M, Ngai P, Santosuosso M, Millar J, Zganiacz A, Wang J, Bramson J, Xing Z: Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Vaccine (2007) 25(7):1342-1352.
33. Yen HH, Scheerlinck JP: Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation. Vaccine (2007) 25(14):2575-2582.
34. Saha S, Takeshita F, Sasaki S, Matsuda T, Tanaka T, Tozuka M, Takase K, Matsumoto T, Okuda K, Ishii N, Yamaguchi K et al: Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa. Vaccine (2006) 24(37-39):6240-6249.
35. Hu H, Lu X, Tao L, Bai B, Zhang Z, Chen Y, Zheng F, Chen J, Chen Z, Wang H: Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice. Clin Vaccine Immunol (2007) 14(7):894-901.
36. Siemann DW, Bibby MC, Dark GG, Dicker AP, Eskens FA, Horsman MR, Marmé D, Lorusso PM: Differentiation and definition of vascular-targeted therapies. Clin Cancer Res (2005) 11(2 Pt 1):416-420.
37. Tozer GM, Kanthou C, Baguley BC: Disrupting tumour blood vessels. Nat Rev Cancer (2005) 5(6):423-435.
38. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, Coer A, Swartz HM, Cemazar M: Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer (2002) 87(9):1047-1054.
39. Kanthou C, Kranjc S, Sersa G, Tozer G, Zupanic A, Cemazar M: The endothelial cytoskeleton as a target of electroporation-based therapies. Mol Cancer Ther (2006) 5(12):3145-3152.
40. F10 melanoma tumours. Acta Biochim Pol (2006) 53(1):199-202.
41. Shibata MA, Morimoto J, Doi H, Morishima S, Naka M, Otsuki Y: Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis. Cancer Gene Ther (2007) 14(3):268-278. • Vascular targeted electrogene therapy against growth of distant metastases was assessed.
42. Moolten FL: Tumor chemosensitivity conferred by inserted herpes virus thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res (1986) 46(10):5276-5281.
43. Pedron-Mazoyer S, Plouët J, Hellaudais L, Teissie J, Golzio M: New anti angiogenesis developments through electro-immunization: Optimization by in vivo optical imaging of intradermal electro gene transfer. Biochim Biophys Acta (2007) 1770(1):137-142.
44. Li S, Zhang L, Torrero M, Cannon M, Barret R: Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer. Mol Ther (2005) 12(5):942-949.
45. Torrero MN, Xia X, Henk W, Yu S, Li S: Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression. Cancer Res (2006) 66(8):4461-4467.
46. Shibata MA, Ito Y, Morimoto J, Kusakabe K, Yoshinaka R, Otsuki Y: In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas. J Gene Med (2006) 8(3):335-352.
47. Heller L, Merkler K, Westover J, Cruz Y, Coppola D, Benson K, Daud A, Heller R: Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model. Clin Cancer Res (2006) 12(10):3177-3183. •• Toxicity following electrogene therapy with IL-12 was characterized in normal tissue.
48. Yamashita YI, Shimada M, Hasegawa H, Minagawa R, Rikimaru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI, Sugimachi K: Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res (2001) 61(3):1005-1012.
49. Lucas ML, Heller R. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol (2003) 22(12):755-763.
50. Mahvi DM, Henry MB, Albertini MR, Weber S, Meredith K, Schalch H, Rakhmilevich A, Hank J, Sondel P: Intratumoral injection of IL-12 plasmid DNA - results of a phase I/Ib clinical trial. Cancer Gene Ther (2007) 14(8):717-723.
51. Heller LC, Heller R: In vivo electroporation for gene therapy. Hum Gene Ther (2006) 17(9):890-897.
52. Ugen KE, Kutzler MA, Marrero B, Westover J, Coppola D, Weiner DB, Heller R: Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation. Cancer Gene Ther (2006) 13(10):969-974.
53. Collins CG, Tangney M, Larkin JO, Casey G, Whelan MC, Cashman J, Murphy J, Soden D, Vejda S, McKenna S, Kiely B et al: Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors. Cancer Gene Ther (2006) 13(12):1061-1071.
54. Chen WY, Cheng YT, Lei HY, Chang CP, Wang CW, Chang MS: IL-24 inhibits the growth of hepatoma cells in vivo. Genes Immun (2005) 6(6):493-499.
55. Shimao K, Takayama T, Enomoto K, Saito T, Nagai S, Miyazaki J, Ogawa K, Tahara H: Cancer gene therapy using in vivo electroporation of Flt3-ligand. Int J Oncol (2005) 27(2):457-463.
56. McCray AN, Ugen KE, Muthumani K, Kim JJ, Weiner DB, Heller R: Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation. Mol Ther (2006) 14(5):647-655.
57. Grosel A, Sersa G, Kranjc S, Cemazar M: Electrogene therapy with p53 of murine sarcomas alone or combined with electrochemotherapy using cisplatin. DNA Cell Biol (2006) 25(12):674-683.
58. Shibata MA, Miwa Y, Miyashita M, Morimoto J, Abe H, Otsuki Y: Electrogene transfer of an Epstein-Barr virus-based plasmid replicon vector containing the diphtheria toxin A gene suppresses mammary carcinoma growth in SCID mice. Cancer Sci (2005) 96(7):434-440.
59. Matsubara H, Mizutani Y, Hongo F, Nakanishi H, Kimura Y, Ushijima S, Kawauchi A, Tamura T, Sakata T, Miki T: Gene therapy with TRAIL against renal cell carcinoma. Mol Cancer Ther (2006) 5(9):2165-2171.
60. Tsurushima H, Yuan X, Dillehay LE, Leong KW: Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors. Cancer Gene Ther (2007) 14(8):706-716. • First description of the successful use of electrogene therapy in combination with radio-inducible promoters.
61. Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L, Bieth A, Pillaire MJ, Cazaux C, Hoffmann JS, Couderc B, Teissié J: In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther (2007) 14(9):752-759.
62. Nakai N, Kishida T, Shin-Ya M, Imanishi J, Ueda Y, Kishimoto S, Mazda O: Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf. Gene Ther (2007) 14(4):357-365.
63. Fan Y, Xin XY, Chen BL, Ma X: Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo. Pathology (2006) 38(6):561-567.
64. Cascante A, Huch M, Rodríguez LG, González JR, Costantini L, Fillat C: Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo. Hum Gene Ther (2005) 16(12):1377-1388.
65. Deharvengt S, Rejiba S, Wack S, Aprahamian M, Hajri A: Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine. Int J Oncol (2007) 30(6):1397-1406.
66. Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P: Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Mol Ther (2006) 13(2):320-327.
67. Buchan S, Grønevik E, Mathiesen I, King CA, Stevenson FK, Rice J: Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen. J Immunol (2005) 174(10):6292-6298. • This study demonstrated that electroporation was an effective delivery method for DNA vaccination and that electrotransfer boosted the immunological response and improved vaccine performance.
68. Schjetne KW, Fredriksen AB, Bogen B: Delivery of antigen to CD40 induces protective immune responses against tumors. J Immunol (2007) 178(7):4169-4176.
69. Rice J, Dunn S, Piper K, Buchan SL, Moss PA, Stevenson FK: DNA fusion vaccines induce epitope-specific cytotoxic CD8+ T-cells against human leukemia-associated minor histocompatibility antigens. Cancer Res (2006) 66(10):5436-5442.
70. Aurisicchio L, Mennuni C, Giannetti P, Calvaruso F, Nuzzo M, Cipriani B, Palombo F, Monaci P, Ciliberto G, La Monica N: Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates. Int J Cancer (2007) 120(11):2290-2300.
71. Fredriksen AB, Bogen B: Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences. Blood (2007) 110(6):1797-1805.
72. Onodera S, Ohshima S, Tohyama H, Yasuda K, Nishihira J, Iwakura Y, Matsuda I, Minami A, Koyama Y: A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum (2007) 56(2):521-530.
73. Khoury M, Bigey P, Louis-Plence P, Noel D, Rhinn H, Scherman D, Jorgensen C, Apparailly F: A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis. J Gene Med (2006) 8(8):1027-1036.
74. Gould D, Yousaf N, Fatah R, Subang MC, Chernajovsky Y: Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-α inhibitor in experimental arthritis. Arthritis Res Ther (2007) 9(1):R7.
75. Grossin L, Cournil-Henrionnet C, Pinzano A, Gaborit N, Dumas D, Etienne S, Stoltz JF, Terlain B, Netter P, Mir LM, Gillet P: Gene transfer with Hsp70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis. FASEB J (2006) 20(1):65-75.
76. Lee TH, Jawan B, Chou WY, Lu CN, Wu CL, Kuo HM, Concejero AM, Wang CH: α-Melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice. J Gene Med (2006) 8(6):764-772.
77. Wang CH, Lee TH, Lu CN, Chou WY, Hung KS, Concejero AM, Jawan B: Electroporative α-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation. Gene Ther (2006) 13(13):1000-1009.
78. Hung KS, Lee TH, Chou WY, Wu CL, Cho CL, Lu CN, Jawan B, Wang CH: Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice. Biochem Biophys Res Commun (2005) 336(1):324-331.
79. Chi CH, Liu IL, Lo WY, Liaw BS, Wang YS, Chi KH: Hepatocyte growth factor gene therapy prevents radiation-induced liver damage. World J Gastroenterol (2005) 11(10):1496-1502.
80. Long YC, Jaichandran S, Ho LP, Tien SL, Tan SY, Kon OL: FVIII gene delivery by muscle electroporation corrects murine hemophilia A. J Gene Med (2005) 7(4):494-505.
81. Mei WH, Qian GX, Zhang XQ, Zhang P, Lu J: Sustained expression of Epstein-Barr virus episomal vector mediated Factor VIII in vivo following muscle electroporation. Haemophilia (2006) 12(3):271-279.
82. Soltani N, Kumar M, Glinka Y, Prud'homme GJ, Wang Q: In vivo expression of GLP-1/IgG-Fc fusion protein enhances β-cell mass and protects against streptozotocin-induced diabetes. Gene Ther (2007) 14(12):981-988.
83. Murakami T, Arai M, Sunada Y, Nakamura A: VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice. J Gene Med (2006) 8(6):773-781.
84. Diao WF, Chen WQ, Wu Y, Liu P, Xie XL, Li S, Shen PP, Ji J: Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation. Proteomics (2006) 6(21):5837-5845.
85. Schakman O, Gilson H, de Coninck V, Lause P, Verniers J, Havaux X, Ketelslegers JM, Thissen JP: Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats. Endocrinology (2005) 146(4):1789-1797.
86. Franquesa M, Alperovich G, Herrero-Fresneda I, Lloberas N, Bolanos N, Fillat C, Rama I, Cruzado JM, Grinyo JM, Torras J: Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure. Gene Ther (2005) 12(21):1551-1558.
87. Herrero-Fresneda I, Torras J, Franquesa M, Vidal A, Cruzado JM, Lloberas N, Fillat C, Grinyó JM: HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int (2006) 70(2):265-274.
88. Tavakoli R, Gazdhar A, Pierog J, Bogdanova A, Gugger M, Pringle IA, Gill DR, Hyde SC, Genoni M, Schmid RA: Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts. J Gene Med (2006) 8(2):242-248.
89. Jaini R, Hannaman D, Johnson JM, Bernard RM, Altuntas CZ, Delasalas MM, Kesaraju P, Luxembourg A, Evans CF, Tuohy VK: Gene-based intramuscular interferon-β therapy for experimental autoimmune encephalomyelitis. Mol Ther (2006) 14(3):416-422.
90. Ho SH, Lee HJ, Kim DS, Jeong JG, Kim S, Yu SS, Jin Z, Kim S, Kim JM: Intrasplenic electro-transfer of IL-4 encoding plasmid DNA efficiently inhibits rat experimental allergic encephalomyelitis. Biochem Biophys Res Commun (2006) 343(3):816-824.
91. Wong SH, Lowes KN, Quigley AF, Marotta R, Kita M, Byrne E, Kornberg AJ, Cook MJ, Kapsa RM: DNA electroporation in vivo targets mature fibres in dystrophic mdx muscle. Neuromuscul Disord (2005) 15 (9-10):630-641.
92. Seidler RW, Allgäuer S, Ailinger S, Sterner A, Dev N, Rabussay D, Doods H, Lenter MC: In vivo human MCP-1 transfection in porcine arteries by intravascular electroporation. Pharm Res (2005) 22(10):1685-1691.
93. Portlock JL, Keravala A, Bertoni C, Lee S, Rando TA, Calos MP: Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage φC31 integrase after nonviral DNA delivery. Hum Gene Ther (2006) 17(8):871-876.
94. Hojman P, Gissel H, Gehl J: Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation. Gene Ther (2007) 14(12):950-959.
95. Fattori E, Cappelletti M, Zampaglione I, Mennuni C, Calvaruso F, Arcuri M, Rizzuto G, Costa P, Perretta G, Ciliberto G, La Monica N: Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates. J Gene Med (2005) 7(2):228-236.
96. Ishikawa H, Takano M, Matsumoto N, Sawada H, Ide C, Mimura O, Dezawa M: Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode. Gene Ther (2005) 12(4):289-298.
97. Bloquel C, Bejjani R, Bigey P, Bedioui F, Doat M, BenEzra D, Scherman D, Behar-Cohen F: Plasmid electrotransfer of eye ciliary muscle: Principles and therapeutic efficacy using hTNF-α soluble receptor in uveitis. FASEB J (2006) 20(2):389-391.
98. Kim JM, Lim BK, Ho SH, Yun SH, Shin JO, Park EM, Kim DK, Kim S, Jeon ES: TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis. Biochem Biophys Res Commun (2006) 344(3):765-771.
99. Lin MP, Marti GP, Dieb R, Wang J, Ferguson M, Qaiser R, Bonde P, Duncan MD, Harmon JW: Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model. Wound Repair Regen (2006) 14(5):618-624.
100. Potteaux S, Deleuze V, Merval R, Bureau MF, Esposito B, Scherman D, Tedgui A, Mallat Z: In vivo electrotransfer of interleukin-10 cDNA prevents endothelial upregulation of activated NF-κB and adhesion molecules following an atherogenic diet. Eur Cytokine Netw (2006) 17(1):13-18.
101. +-ATPase rescues endotoxin-induced lung injury. Am J Respir Crit Care Med (2007) 176(6):582-590.